Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
United States (2)
Other
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical Company (9)
Payers (usually governmental or public bodies, reimbursement)
Representativeness of stakeholders
Clinical study phase II